Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · Real-Time Price · USD
3.470
+0.470 (15.67%)
At close: Nov 22, 2024, 4:00 PM
3.509
+0.039 (1.14%)
After-hours: Nov 22, 2024, 7:56 PM EST
Perspective Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Strong Buy
Price Target
$20.88
Upside
+501.73%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $22 → $16 | Buy | Maintains | $22 → $16 | +361.10% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Reiterates $20 | Buy | Reiterates | $20 | +476.37% | Oct 24, 2024 |
| UBS | UBS | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +476.37% | Oct 24, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $22 | Buy | Reiterates | $22 | +534.01% | Oct 11, 2024 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +620.46% | Oct 1, 2024 |
| Truist Securities | Truist Securities | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +505.19% | Sep 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 6, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 3, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $29 → $27 | Buy | Maintains | $29 → $27 | +678.10% | Aug 16, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $19 → $17 | Buy | Maintains | $19 → $17 | +389.91% | Aug 13, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +591.64% | Jul 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $2 → $19 | Buy | Reiterates | $2 → $19 | +447.55% | Jun 18, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.